Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;20(10):555-561.
doi: 10.1080/14796678.2024.2365552. Epub 2024 Jul 5.

Relationship between angiogenesis biomarker endocan and apolipoproteins in patients with acute myocardial infarction

Affiliations

Relationship between angiogenesis biomarker endocan and apolipoproteins in patients with acute myocardial infarction

Mehdi Hassanpour et al. Future Cardiol. 2024.

Abstract

Aim: In the current study, serum levels of endocan in patients attended with ST-elevation myocardial infarction, as well as the possible correlation with apolipoprotein-A1 (APO-A1) and APO-B were investigated.Materials & methods: In 80 men, endocan, cTnI, APO-A1, and APO-B levels were measured. Finally, the correlation of endocan with APO-A1, APO-B, and APO-B/ APO-A1 ratio was assessed.Results: Significant changes in APO-A1, APO-B, endocan levels, and APO-B/APO-A1 ratio were found in acute myocardial infarction cases compared with the control arm (p < 0.05). In addition, our finding showed a significant correlation between APO-B and endocan levels, but not APO-A.Conclusion: High endocan level is an independent indicator of endothelial dysfunction and ischemic cardiovascular conditions, which could be related to APO-B.

Keywords: ST-elevation myocardial infarction; acute myocardial infarction; angiogenesis; apolipoproteins; endocan; reliable indicator.

Plain language summary

[Box: see text].

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Figures

Figure 1.
Figure 1.
The serum levels of endocan, APO-A1, and APO-B. As shown in this figure, the levels of APO-B, endocan, and cTnI are significantly higher in AMI patients compared with healthy subjects. However, serum levels of APO-A1 are lowered in AMI conditions. AMI: Acute myocardial infarction; APO-A and -B: Apolipoprotein A and -B; cTnI: Cardiac troponin I; Endo: Endocan.

Similar articles

References

    1. Osho A, Fernandes MF, Poudel R, et al. Race-based differences in ST-segment–elevation myocardial infarction process metrics and mortality from 2015 through 2021: an analysis of 178 062 patients from the American Heart Association get with the guidelines–coronary artery disease registry. Circulation. 2023;148(3):229–240. doi: 10.1161/CIRCULATIONAHA.123.065512 - DOI - PubMed
    1. Napoli G, Pergola V, Basile P, et al. Epicardial and pericoronary adipose tissue, coronary inflammation, and acute coronary syndromes. J Clin Med. 2023;12(23). doi: 10.3390/jcm12237212 - DOI - PMC - PubMed
    1. Sharifi F, Mousavinasab S, Soruri R, et al. High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population. Metab Syndr Relat Disord. 2008;6(3):187–195. doi: 10.1089/met.2008.0007 - DOI - PubMed
    1. Corbo R, Vilardo T, Mantuano E, et al. Apolipoproteins B and E, and angiotensin I‐converting enzyme (ACE) genetic polymorphisms in Italian women with coronary artery disease (CAD) and their relationships with plasma lipid and apolipoprotein levels. Clin Genet. 1997;52(2):77–82. doi: 10.1111/j.1399-0004.1997.tb02522.x - DOI - PubMed
    1. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045–2051. doi: 10.1161/ATVBAHA.108.179705 - DOI - PMC - PubMed

LinkOut - more resources